142 related articles for article (PubMed ID: 4796118)
1. Structure-activity correlations of anticancer agents: diaminopyrimidines, N-acyltriamines, bis-(1-aziridinyl)-phosphinyl carbamates, and aromatic nitrogen mustards.
Lien EJ; Tong GL
Cancer Chemother Rep; 1973; 57(3):251-61. PubMed ID: 4796118
[No Abstract] [Full Text] [Related]
2. [Research on compounds with antiblastic activity. XLI. Synthesis of new nitrogen mustards correlated with N,N-bis-(beta-chlorethyl) aniline].
Artico M; Filacchioni G; Vomero S
Farmaco Sci; 1971 Sep; 26(9):805-11. PubMed ID: 5157547
[No Abstract] [Full Text] [Related]
3. SYNTHESIS OF POTENTIAL DUAL ANTAGONISTS. 3. RING-SUBSTITUTED ETHYL (BIS(1-AZIRIDINYL)PHOSPHINYL)CARBAMATES.
BARDOS TJ; BARUA AK; CHMIELEWICZ ZF; CREVAR GE; DAILEY JP; DIVALD S; PAPANASTASSIOU ZB
J Pharm Sci; 1965 Feb; 54():187-90. PubMed ID: 14293801
[No Abstract] [Full Text] [Related]
4. Anticancer activity of P,P-bis(2-methyl-1-aziridinyl)-N-2-pyrimidinylphosphinic amide (methylphosphazine) and related compounds.
Noell CW; Cheng CC
J Med Chem; 1968 Jan; 11(1):63-6. PubMed ID: 4966062
[No Abstract] [Full Text] [Related]
5. SYNTHESIS OF POTENTIAL DUAL ANTAGONISTS IV. EFFECT OF RING SUBSTITUENTS ON THE ALKYLATING AND HYDROLYTIC PROPERTIES OF BIS-(1-AZIRIDINYL)PHOSPHINYL CARBAMATES.
BARDOS TJ; CHMIELEWICZ ZF; NAVADA CK
J Pharm Sci; 1965 Mar; 54():399-403. PubMed ID: 14302149
[No Abstract] [Full Text] [Related]
6. Isomer-dependent cytostatic activity of bis(1-aziridinyl)cyclophosphazenes.
van der Huizen AA; Wilting T; van de Grampel JC; Lelieveld P; van der Meer-Kalverkamp A; Lamberts HB; Mulder NH
J Med Chem; 1986 Aug; 29(8):1341-5. PubMed ID: 3735303
[TBL] [Abstract][Full Text] [Related]
7. Potential anticancer agents. V. New aromatic nitrogen mustards related to 3-[N,N-bis(2-chloroethyl)amino]-4-methylbenzoic acid.
Cambanis A; Dobre V; Niculescu-Duvăz I
J Med Chem; 1969 Jan; 12(1):161-4. PubMed ID: 5763014
[No Abstract] [Full Text] [Related]
8. Synthesis of new bis(1-aziridinyl) phosphinate alkylating agents containing O-phenyl N-phenylcarbamate side chains.
Hsiao YY; Bardos TJ
J Med Chem; 1973 Apr; 16(4):391-4. PubMed ID: 4716182
[No Abstract] [Full Text] [Related]
9. [Preliminary results of 10 patients with advanced prostatic neoplasm treated with estracyt].
de Leval J; Petit R; Bouffioux C
Acta Urol Belg; 1974 Jul; 42(3):326-35. PubMed ID: 4440596
[No Abstract] [Full Text] [Related]
10. [Chemotherapy of malignant tumors. 44].
Seidenglanz G
Pharm Prax; 1970; 6():122-38. PubMed ID: 4917035
[No Abstract] [Full Text] [Related]
11. SYNTHESIS OF POTENTIAL "DUAL ANTAGONISTS." I. SOME BIS(1-AZIRIDINYL)PHOSPHINYL CARBAMATES AND THEIR STRUCTURAL ANALOGS.
PAPANASTASSIOU ZB; BARDOS TJ
J Med Pharm Chem; 1962 Sep; 5():1000-7. PubMed ID: 14056423
[No Abstract] [Full Text] [Related]
12. [Results of the clinical study of a preparation of diiodobenzotef in malignant tumors].
Karev NI; Garin AM; Blokhina NG; Pershin MP; Trapeznikova MF
Klin Med (Mosk); 1975 May; 52(5):50-3. PubMed ID: 1133992
[No Abstract] [Full Text] [Related]
13. Estrogen-linked cytotoxic agents of potential value for the treatment of breast cancer.
Leclercq G; Devleeschouwer N; Legros N; Heuson JC
Eur J Cancer (1965); 1980; Suppl 1():287-93. PubMed ID: 7318866
[No Abstract] [Full Text] [Related]
14. [Structure-activity relationship in Mannich bases with and without nitrogen mustard groups and in various reduction products derived from beta-aminoketones as evidenced with the aid of a cancerostatic 3-step test using transplantation tumors].
Werner W; Jungstand W; Gutsche W; Wohlrabe K
Pharmazie; 1977 Jun; 32(6):341-7. PubMed ID: 896938
[No Abstract] [Full Text] [Related]
15. Potential anticancer agents. II. Urethan-type nitrogen mustards of some natural sex hormones.
Niculescu-Duvăz I; Cambanis A; Tărnăuceanu E
J Med Chem; 1967 Mar; 10(2):172-4. PubMed ID: 6034059
[No Abstract] [Full Text] [Related]
16. Resarch on new Schiff bases with antiblastic activity. Carcinostatic activities of 3-p-(2',5'-dimethoxy-4'-(N,N-bis( -chloroethyl)-amino)benzylideneamino)phenyl-2-oxazolidinone (GEA 29 = BAY a 5850).
Pütter J; Maral R; Bierling R; Steinhoff D
Farmaco Sci; 1971 Sep; 26(9):784-804. PubMed ID: 5157546
[No Abstract] [Full Text] [Related]
17. Potential anticancer agents. VII. Relationship between basicity of precursor unsubstituted amines and hydrolysis rate of corresponding aromatic nitrogen mustards.
Niculescu-Duvaz I; Botez G; Serban A
Neoplasma; 1970; 17(2):143-54. PubMed ID: 5425392
[No Abstract] [Full Text] [Related]
18. Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate.
Müntzing J; Shukla SK; Chu TM; Mittelman A; Murphy GP
Invest Urol; 1974 Jul; 12(1):65-8. PubMed ID: 4835492
[No Abstract] [Full Text] [Related]
19. Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines.
Palmer BD; Wilson WR; Pullen SM; Denny WA
J Med Chem; 1990 Jan; 33(1):112-21. PubMed ID: 2296009
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, antineoplastic activity, and chemical properties of bis(carbamate) derivatives of 4,5-bis(hydroxymethyl)imidazole.
Anderson WK; Bhattacharjee D; Houston DM
J Med Chem; 1989 Jan; 32(1):119-27. PubMed ID: 2909723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
